Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-29

Clinical Trial Update: Mag Con: Efficacy of Oral Mag. in Acute Concussion in Adolescents [NA]

View source ↗

Summary

A clinical trial evaluating oral magnesium (Mag Con) for acute concussion in adolescents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mag Con (magnesium)

Snippet

Sponsor: Corewell Health South | Conditions: Concussion, Mild, Traumatic Brain Injury, Mild | NA | Status: WITHDRAWN